Guide for patients & caregivers
Detectable Hepatitis B DNA (Viral Load): What Does the Number Mean?
Detectable hepatitis B DNA explained: what the viral load number in IU/mL shows, why it changes, how it guides monitoring and treatment, and what to ask next.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does a detectable hepatitis B DNA result mean?
A detectable hepatitis B DNA result means genetic material from the hepatitis B virus (HBV) was found in your blood. The CDC describes HBV DNA as a measure of viral load: the higher the number, the more virus is circulating. Clinicians read it with other hepatitis B markers, liver tests and scans to plan monitoring and decide whether treatment is needed.
This guide is for adults with a hepatitis B DNA (viral load) result, usually after a positive hepatitis B surface antigen (HBsAg) test. It explains the number in general terms and cannot interpret an individual result. The basics of a positive HBsAg test, including acute versus chronic infection and protecting contacts, are covered in a separate guide.
Symptoms that need urgent care
A viral load result is rarely urgent by itself, and many people with hepatitis B feel well. Some symptoms need faster attention than a routine appointment.
- Yellowing of the skin or the whites of the eyes (jaundice), possibly with itchy skin, darker urine or paler stools: NHS advises asking for an urgent GP appointment or getting help from NHS 111, or the equivalent urgent service where you live.
- Confusion or difficulty thinking, or swelling of the abdomen or ankles: NIDDK lists these among signs of cirrhosis. Seek prompt medical care, and emergency care if symptoms are severe or getting worse quickly.
- New symptoms after stopping hepatitis B medicine: tell the treating team quickly, because sources describe severe reactivation as a possible risk after antiviral treatment stops.
How is the hepatitis B viral load number reported?
Most laboratories report HBV DNA in international units per millilitre (IU/mL), the unit used in WHO and CDC guidance. Some reports also show a logarithmic (log) value, and older studies used copies per millilitre, which is a different unit. Each test also has its own lower limit, so a result may be reported as below a limit, not detected, or as an exact number.
There is no single normal range for someone living with hepatitis B. What a number means depends on the test used, the unit, your other results and how it compares with earlier values. Ask the clinician to explain your report rather than comparing it with numbers found online.
Why can hepatitis B DNA levels go up and down?
Viral load changes as the infection and the immune response change. A review in the journal Viruses explains that in HBeAg-negative chronic hepatitis B, at least one third of people show large swings in HBV DNA, with temporary drops below commonly used thresholds. Because of this, the authors say that a single test at one time point is not enough to tell some patterns apart.
HBeAg status also matters. The CDC Pink Book links a positive HBeAg with high levels of HBV DNA and higher infectivity, and the antibody anti-HBe with less replicating virus. This is why viral load is usually repeated over months or years, alongside ALT, rather than judged from one sample.
Can hepatitis B DNA be detectable with a negative HBsAg?
Yes, occasionally. The 2023 CDC recommendations describe occult hepatitis B infection, in which HBsAg is negative but HBV DNA is positive. The CDC Pink Book notes that HBV DNA tests can detect this kind of infection. It is often considered when the hepatitis B core antibody is positive, which a separate guide explains, or before immune-suppressing treatment.
How does viral load affect treatment decisions?
Viral load is one input, not the whole decision. NIDDK states that not everyone with chronic hepatitis B needs treatment, and that doctors may prescribe antiviral medicines if blood tests show the virus could be damaging the liver.
The 2024 WHO guidelines give several routes to treatment for adults and adolescents. They include significant liver scarring whatever the viral load, an HBV DNA level above 2,000 IU/mL together with an ALT above the upper limit of normal (previously above 20,000 IU/mL), and other factors such as coinfection with HIV, hepatitis C or hepatitis D, or a family history of liver cancer or cirrhosis. Where HBV DNA testing is not available, WHO suggests treatment based on persistently abnormal ALT. National guidelines and specialist societies may use different thresholds.
In pregnancy, viral load helps decide whether to lower the chance of passing the virus to the baby. The CDC Pink Book says all pregnant women who are HBsAg positive should have HBV DNA tested, and that AASLD suggests antiviral treatment from the third trimester when maternal HBV DNA is above 200,000 IU/mL. The 2024 WHO guidelines also include a positive HBeAg in their criteria and conditionally recommend antiviral prevention for all HBsAg-positive pregnant women. NIDDK adds that the baby should receive the hepatitis B vaccine and hepatitis B immune globulin right after birth.
What happens to viral load during treatment?
The CDC Pink Book notes that HBV DNA tests are used to monitor response to treatment. The WHO fact sheet says treatment can slow cirrhosis and reduce liver cancer, and that most people who start hepatitis B treatment need to continue it for life.
NIDDK advises not to stop hepatitis B antiviral medicines without first talking with your doctor. The Viruses review describes possible severe reactivations after treatment is stopped, and says European guidance limits stopping to selected patients who can have frequent ALT and HBV DNA tests afterwards. Any change is a decision for the specialist. Tell any doctor planning chemotherapy or other immune-suppressing treatment about your hepatitis B, because NIDDK notes the virus can reactivate.
Whether or not you take treatment, Healthdirect advises regular check-ups to watch for liver damage and, for some people, regular liver cancer screening.
Questions to ask your specialist
Bring your recent and earlier reports so the numbers can be compared.
- What is my HBV DNA level, in which unit, and what is this test's lower limit?
- How has my viral load changed compared with earlier results?
- What do my HBeAg, ALT and liver stiffness or scan results show alongside it?
- Which treatment criteria does this service use, and do I meet any of them now?
- How often will my viral load and liver tests be repeated?
- If I am on treatment, what result would show it is working?
- If I am pregnant or planning a pregnancy, how will my viral load change the plan?
How comparing similar cases on SameCase can help you prepare
On SameCase, patients and verified doctors share de-identified cases. Seeing how other people recorded their viral load results over time, and which questions they asked about monitoring and treatment, can help you organise your own reports. Similar cases cannot predict your results or tell you whether you need treatment; your specialist decides that with your full history.
Sources and further reading
- CDC MMWR: Screening and testing for hepatitis B virus infection, recommendations (2023)
- CDC Pink Book: Hepatitis B chapter, HBV DNA and serologic markers (May 2024)
- WHO 2024 chronic hepatitis B guidelines, executive summary (PMC text extract)
- WHO: Hepatitis B fact sheet (July 2026)
- NIDDK: Hepatitis B, diagnosis, treatment and pregnancy (reviewed December 2024)
- Viruses (CC BY 4.0): HBeAg-negative/anti-HBe-positive chronic hepatitis B review (2022)
- NHS: Jaundice and urgent medical advice (reviewed January 2024)
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.